Haig P. Bozigian, Chief Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,985 shares at $88.18 ($439K) on 2019-02-05, disclosed to the SEC on 2019-02-06.
Seasonal sale ($439k) by Chief Development Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.10 | 1,375 | $121K | 27.6% |
| 2 | $88.10 | 1,375 | $121K | 27.6% |
| 3 | $88.06 | 465 | $41K | 9.3% |
| 4 | $88.18 | 885 | $78K | 17.8% |
| 5 | $88.18 | 885 | $78K | 17.8% |
| Total | $88.12 avg | 4,985 |
| $439K |
| 100% |
| Filing → |
| NBIX | SELL | 2020-08-07 | $537K | — | Filing → |
| NBIX | SELL | 2020-05-14 | $14.2M | — | Filing → |
| NBIX | SELL | 2020-04-28 | $385K | — | Filing → |